Humanized monoclonal antibody
PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis
... mAb: Monoclonal antibody; NHP: Non-human primate; NK: Natural killer; NSG: NOD scid gamma chain knockout; OCT: Optimal cutting temperature; PBMC: Peripheral blood mononuclear cells; PBS: Phosphate-buffered ...
15
Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
... for antibody-mediated reduction of tau pathology observed in mouse models, and supported the feasibility of using anti-tau immunotherapy in a clinical ...of antibody-mediated reduction of pathological tau ...
18
Humanized Monoclonal Antibody That Passively Protects Mice against Systemic and Intranasal Ricin Toxin Challenge
... genetically fused to human IgG1 and constant regions, respec- tively, and then we expressed this construct by using a Nicotiana benthamiana-based rapid antibody-manufacturing platform (RAMP) (12). cPB10 proved ...
5
Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
... Notes: (A) 4T1 cells were treated with a constant amount of human IL-17A wild type, mutant h1, or vector control supernatant in the presence of increasing amounts of ixekizumab (closed symbols) or isotope control ...
12
Humanized Monoclonal Antibody for Prevention of Respiratory Syncytial Virus Infection
... mouse monoclonal antibody onto a human immuno- globulin ...mouse monoclonal antibody used to create palivizumab recognizes a protective epitope of the fusion or F glycoprotein of ...
6
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice
... tested antibody concentration of 1 mg/kg was ...the antibody did restore complete protection and limit ...of antibody dosage required for effective treatment versus the time of treat- ment after ...
10
Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate
... an antibody -drug immunoconjugate that consists of a humanized monoclonal antibody (M9346A) targeting folate receptor alpha (FRα)-positive cancer cells [4] attached to a highly potent ...
10
Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)
... the humanized monoclonal antibody palivizumab has been shown to reduce the rate of RSV hospitalization in premature infants and those infants with chronic lung disease or congenital heart ...potent ...
12
Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients
... a humanized monoclonal antibody that binds human CD4, the primary receptor for human immunodeficiency virus type 1 ...this antibody potently and broadly blocks HIV-1 infection in vitro by ...
8
Potential role of daratumumab in the treatment of multiple myeloma
... recently, monoclonal antibody therapies have not yielded success in the treatment of ...a humanized monoclonal antibody against CD20, as the first FDA-approved monoclonal ...
6
Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents
... cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises several clinical entities with diverse clinical presentations, outcomes, and nonunifying ...anti-CD20 antibody rituximab has proved ...
15
New developments in the management of advanced melanoma – role of pembrolizumab
... selective humanized monoclonal antibody directly blocking the interaction between programmed cell death-1 expressed by tumor-associated T-cells and its ligand programmed cell death-L1 present on ...
9
Anti-Angiogenesis Therapy of Cancer Cells using 153Sm-Bevasesomab
... The humanized monoclonal antibody bevacizumab, directed against vascular endothelial growth factor (VEGF), is the first and currently the only anti-angiogenic agent to be approved for cancer therapy ...
10
Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants
... IMpact-RSV was a multicenter, randomized (2 treatment to 1 control), double-blind, placebo-controlled trial conducted at 139 centers in the United States (n 5 119), Canada (n 5 9), and the United Kingdom (n 5 11). ...
9
Questions About Palivizumab (Synagis)
... Lastly, Dr Moler suggests that education may be a cost-effective alternative method for RSV prevention. This is clearly an impor- tant issue for the pediatric provider but will require formal assess- ment of the range of ...
5
Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis
... Abstract: Management of psoriasis is a challenge to the treating physician. The chronic inflam- matory state of psoriasis with exacerbations and remissions necessitate “on-and-off ” treatment schedules. The safety ...
8
Managing refractory Crohn's disease: challenges and solutions
... Combination therapy of ADA plus intensive GMA, or IFX plus AZA, is considered to be useful for the treatment of patients with refractory CD due to the high rate of induction of remission. These therapeutic strategies are ...
10
A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition
... in antibody dilution buffer (5 % bovine serum albumin, ...p21cip/waf1 antibody, which was diluted at ...polyclonal antibody) diluted 1:1000 with dilution buffer for 1 h at room temperature and ...
10
Minute Virus of Mice NS1 Interacts with the SMN Protein, and They Colocalize in Novel Nuclear Bodies Induced by Parvovirus Infection
... (primary antibody: anti-NS1 polyclonal; secondary antibody: anti-rabbit FITC conjugate) and VP1 (primary antibody: anti-VP1 polyclonal peptide antibody; secondary antibody: anti-mouse ...
13
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
... The humanized monoclonal IgG2 antibody ADU-1805 binds to all known human SIRP α alleles, showing minimal binding to SIRP β 1, while cross-reacting with SIRP γ , and potently blocking the interaction ...
15